1716
N. T. McDougal et al.
CLUSTER
Stoltz, B. M. Angew. Chem. Int. Ed. 2005, 44, 6924.
(c) Seto, M.; Roizen, J. L.; Stoltz, B. M. Angew. Chem. Int.
Ed. 2008, 47, 6873. (d) Sherden, N. H.; Behenna, D. C.;
Virgil, S. C.; Stoltz, B. M. Angew. Chem. Int. Ed. 2009, 48,
6840.
Pd2dba3 solutions were evaporated to dryness under reduced
pressure using a Genevac centrifugal evaporator within the
glove box. To the dried vials charged with Pd2dba3 was
added 113 mL of the desired solvent to be screened and 18.8
mL of the desired ligand solution (0.02 M in THF). To the
catalyst solutions, which had been stirred at 30 °C for 30
min, was added 30 mL of an enol carbonate 1 solution (0.2 M
in THF) and 38 mL of the same solvent to be screened. The
reactions were stirred at 30 °C for 48 h. The crude reactions
were purified via parallel silica gel chromatography, eluted
with hexane–EtOAc = 5:1, using a Symyx Core Module
within a fume hood. The fractions containing purified 4 were
evaporated to dryness using using a Genevac centrifugal
evaporator.
To each of the 1 mL vials containing purified 4 was added
50 mL of a methyl acrylate solution (0.9 M in CH2Cl2) and
50 mL of a Grubbs second-generation Ru catalyst 6 solution
(0.0055 M in CH2Cl2) using a Symyx Core Module within a
nitrogen-filled glove box. After stirring at 40 °C for 3 h, the
crude reactions were again purified via parallel silica gel
chromatography, eluted with hexane–EtOAc = 3:1, using a
Symyx Core Module within a fume hood. The solutions of
purified product 5 were directly subjected to chiral SFC
analysis to determine ee (%).
(8) Renouf, P.; Poirier, J.-M.; Duhamel, P. J. Org. Chem. 1999,
64, 2513.
(9) For a review, see: Grubbs, R. H. Tetrahedron 2004, 60,
7117.
(10) Reichardt, C. Solvents and Solvent Effects in Organic
Chemistry; VCH: New York, 1988.
(11) Tani, K.; Behenna, D. C.; McFadden, R. M.; Stoltz, B. M.
Org. Lett. 2007, 9, 2529.
(12) Trost, B. M.; Van Vranken, D. L. Chem. Rev. 1996, 96, 395.
(13) Trost, B. M.; Xu, J.; Schmidt, T. J Am. Chem. Soc. 2009,
131, 18343.
(14) McDougal, N. T.; Streuff, J.; Mukherjee, H.; Virgil, S. C.;
Stoltz, B. M. submitted for publication.
(15) Streuff, J.; White, D. E.; Virgil, S. C.; Stoltz, B. M. Nature
Chem. 2010, 2, 192.
(16) Mukherjee, H.; McDougal, N. T.; Virgil, S. C.; Stoltz, B. M.
manuscript in preparation.
(17) Keith, J. A.; Behenna, D. C.; Mohr, J. T.; Ma, S.; Marinescu,
S. C.; Oxgaard, J.; Stoltz, B. M.; Goddard, W. A. III. J. Am.
Chem. Soc. 2007, 129, 11876.
Selected Spectroscopic Data
(18) Trost, B. M.; Radinov, R.; Grenzer, E. M. J. Am. Chem. Soc.
1997, 119, 7879.
(19) Trost, B. M.; Schroeder, G. M.; Kristensen, J. Angew Chem.
Int. Ed. 2002, 41, 3492.
Allyl {6-Methyl-1,4-dioxaspiro[4.5]dec-6-en-7-yl}-
carbonate (1)
1H NMR (300 MHz, CDCl3): d = 5.95 (dddd, J = 18.6, 10.5,
5.7, 5.7 Hz, 1 H), 5.38 (ddd, J = 18.6, 2.7, 1.5 Hz, 1 H), 5.29
(ddd, J = 10.5, 2.7, 1.5 Hz, 1 H), 4.65 (ap dt, J = 5.7, 1.2 Hz,
2 H), 3.97–4.03 (m, 4 H), 2.20–2.27 (m, 2 H), 1.70–1.84 (m,
4 H), 1.58 (t, J = 1.9 Hz, 3 H). 13C NMR (75.0 MHz, CDCl3):
d = 152.1, 147.9, 131.2, 122.7, 118.9, 108.4, 68.6, 65.2, 33.0,
26.7, 19.4, 8.4. IR (thin film): 2952, 2884, 1756, 1700, 1442,
1366, 1346, 1235, 1114, 1036, 993 cm–1. ESI-HRMS: m/z
calcd for C14H19O5 [M + H]+: 255.1227; found: 255.1240.
(E)-Methyl 4-{6-Methyl-7-oxo-1,4-dioxaspiro[4.5]decan-
6-yl}but-2-enoate (5)
(20) Experimental Data
1H NMR and 13C NMR spectra were recorded on a Varian
Mercury 300 (at 300 MHz and 75 MHz, respectively) and
are reported relative to residual CHCl3 (d = 7.26 and 77.0
ppm). IR spectra were recorded on a Perkin Elmer Paragon
1000 spectrometer and are reported in frequency of
absorption (cm–1). High-resolution mass spectra were
recorded on a Agilent 6200 Series Time-of-Flight LC/MS/
TOF system with a Agilent G1978A Multimode source in
electrospray ionization (ESI) mode. Analytical chiral HPLC
for 5 was performed with an Agilent 1100 Series HPLC
utilizing a Chiralcel OD-H column with visualization at 254
nm and a 1 mL/min flow rate of 10% i-PrOH–90% hexane.
Analytical chiral SFC for 5 was performed with a Mettler
supercritical CO2 analytical chromatography system
utilizing a Chiralcel AD-H column with visualization at 254
nm and a 3 mL/min flow rate of 2% i-PrOH–2% MeCN–
96% CO2.
1H NMR (300 MHz, CDCl3): d = 6.92 (ddd, J = 15.3, 6.9, 6.9
Hz, 1 H), 5.80 (d, J = 15.3 Hz, 1 H), 3.91–3.98 (m, 4 H), 3.70
(s, 3 H), 2.66 (dd, J = 14.7, 6.9 Hz, 1 H), 2.39–2.53 (m, 2 H),
2.36 (dd, J = 14.7, 6.9 Hz, 1 H), 1.89–1.94 (m, 2 H), 1.73–
1.84 (m 2 H), 1.16 (s, 3 H). 13C NMR (75.0 MHz, CDCl3):
d = 210.8, 166.5, 145.9, 113.1, 65.1, 64.9, 58.1, 51.3, 36.9,
35.8, 29.5, 19.1, 17.1. IR (thin film): 2954, 2890, 1714,
1654, 1436, 1335, 1273, 1177, 1072, 1030 cm–1. ESI-
HRMS: m/z calcd for C14H21O5 [M + H]+: 269.1384; found:
269.1382. Chiral HPLC: tR(major) = 25.3 min; tR(minor):
34.6 min. Chiral SFC: tR(major) = 10.8 min; tR(minor) = 11.8
min.
Representative Screening Procedure
To 1 mL vials in a 96-well microtiter plate was added 59 mL
of a Pd2dba3 solution (0.0025 M in THF) using a Symyx
Core Module within a nitrogen-filled glove box. The
Synlett 2010, No. 11, 1712–1716 © Thieme Stuttgart · New York